Bulldog Bio to Market Dualsystems' Protein Expression Wares in the US | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bulldog Bio this week announced a deal to sell Dualsystems Biotech's protein expression and analysis systems and products in the US.

Bulldog Bio said the deal is a "long-term relationship," and makes it the single source of all Dualsystems' products in the US, but it didn't provide any additional terms of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.